Key Points

- Humana's stock tumbles after Medicare Advantage rating is lowered by Centers for Medicare and Medicaid Services
- Concerns arise over the company's Medicare Advantage program
- Humana reports decrease in total members enrolled in highly rated Medicare Advantage plans for 2025
- Stock price drops by 12% in premarket trading
- Investors react to news with sharp selloff of Humana shares

Humana's stock faced a significant decline on Tuesday as news broke that the Centers for Medicare and Medicaid Services had decreased its rating on one of the health insurer's prominent Medicare Advantage plans. This sudden turn of events caused concerns among investors, leading to a sharp selloff and pushing the stock to its lowest point in over four years.

The troubling development arose as worries began to mount regarding the performance of Humana's Medicare Advantage program. The government's decision to lower the rating on one of the key plans raised questions about the overall effectiveness and quality of the company's offerings in this sector.

In response to the news, Humana revealed that the total number of members enrolled in its highly rated Medicare Advantage plans for individuals aged 65 and above had declined significantly for the year 2025. This revelation further exacerbated the situation, causing the insurer's shares to plummet by approximately 12% in premarket trading.

Investors reacted swiftly to the announcement, initiating a wave of selling that further drove down Humana's stock price. The sudden decline in membership numbers, coupled with the lowered rating from the government, cast a shadow of doubt over the company's future prospects in the Medicare Advantage market.

As Humana grapples with the fallout from the rating cut and dwindling enrollment figures, the stock market continues to closely monitor the situation. The sharp selloff in Humana's shares serves as a stark reminder of the volatility and uncertainty that can accompany fluctuations in the healthcare sector.

About HUM

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

For more information:

Up/Down Rally

Price Distribution

Analyst Recommendations

Earning Price Impact Analysis

Seasonality